"Prescribing for the whole person": A qualitative study exploring prescribing pharmacist views on type 2 diabetes management in New Zealand

BMC Health Serv Res. 2023 Oct 4;23(1):1058. doi: 10.1186/s12913-023-09877-8.

Abstract

Background: Pharmacist prescribers have comprehensive pharmacotherapy knowledge that can be useful for management of complex health conditions such as type 2 diabetes, yet the number of pharmacist prescribers working in New Zealand primary care is low.

Aim: To explore the experiences of pharmacist prescribers in supporting type 2 diabetes management in New Zealand primary care.

Methods: Qualitative research design using semi-structured interviews with six pharmacist prescribers working in NZ primary care. Thematic analysis guided this study and themes were finalised with the wider research team.

Results: Three major themes were identified: team approach, health inequity and the role of a pharmacist prescriber. This study found that pharmacist prescribers may improve health equity by providing advanced pharmacotherapy knowledge within a wider primary care team to support complex patient needs and understanding the wider social determinants of health that impact effective diabetes management. Participants reportedly had more time to spend with patients (than GPs or nurses) and could also contribute to improving health outcomes by directly educating and empowering patients.

Conclusion: The views of pharmacist prescribers have seldom been explored and this study suggests that their role may be under-utilised in primary care. In particular, pharmacist prescribers can provide specialist prescribing (and often mobile) care, and may contribute to improving health outcomes and reducing inequity when used as part of a multi-disciplinary team.

Keywords: Diabetes; Inequity; Pharmacist prescriber; Primary care.

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Drug Prescriptions
  • Humans
  • New Zealand
  • Pharmacists
  • Qualitative Research